NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Treatment of cancer in humans requires a thorough understanding of the multiple pathways by which it develops. Recent studies suggest that nuclear receptor coactivator 4 (NCOA4) may be a predictive biomarker for renal cancer. In the present work, TCGA, GEPIA, and several bioinformatics approaches we...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Chenzheng, Chang, Wenjing, Wu, Junlu, Yao, Yiwen, Liu, Gege, Yuan, Yi, Quan, Wenqiang, Sun, Zujun, Shang, Anquan, Li, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225891/
https://www.ncbi.nlm.nih.gov/pubmed/35756082
http://dx.doi.org/10.1155/2022/5242437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225891/
https://www.ncbi.nlm.nih.gov/pubmed/35756082
http://dx.doi.org/10.1155/2022/5242437

Ejemplares similares